发明名称 Insulin management
摘要 A method of administering insulin includes receiving blood glucose measurements of a patient at a data processing device from a glucometer. The blood glucose measurements are separated by a time interval. The method also includes receiving patient information at the data processing device and selecting a subcutaneous insulin treatment from a collection of subcutaneous insulin treatments. The selection is based on the blood glucose measurements and the patient information. The selection includes one or more of a subcutaneous standard program, a subcutaneous program without meal boluses, a meal-by-meal subcutaneous program without carbohydrate counting, a meal-by-meal subcutaneous program with carbohydrate counting, and a subcutaneous program for non-diabetic patients. The method also includes executing, using the data processing device, the selected subcutaneous insulin treatment.
申请公布号 US9504789(B2) 申请公布日期 2016.11.29
申请号 US201514938997 申请日期 2015.11.12
申请人 Aseko, Inc. 发明人 Booth Robert C.;Hebblewhite Harry
分类号 G01N33/48;G01N31/00;G06G7/48;G06G7/58;A61M5/172;A61B5/145;G06F19/00;A61B5/00;A61M5/14;A61M5/142 主分类号 G01N33/48
代理机构 Honigman Miller Schwartz and Cohn LLP 代理人 Honigman Miller Schwartz and Cohn LLP
主权项 1. A system comprising: a glucometer measuring blood glucose measurements separated by a time interval; and a dosing controller in communication with the glucometer, the dosing controller including a data processing device and non-transitory memory in communication with the data processing device, the dosing controller: receiving blood glucose measurements of a patient from the glucometer;receiving patient information; andselecting a subcutaneous insulin treatment from a collection of subcutaneous insulin treatments based on the blood glucose measurements and the patient information, the selected subcutaneous insulin treatment includes one or more of a subcutaneous standard program, a subcutaneous program without meal boluses, a meal-by-meal subcutaneous program without carbohydrate counting, a meal-by-meal subcutaneous program with carbohydrate counting, and a subcutaneous program for non-diabetic patients, wherein during the standard subcutaneous program, the dosing controller: determines a blood glucose type of the received blood glucose measurement;determines a correction insulin dose based on the blood glucose type by calculating: CBx=(BGx−BGTarget)/CF;wherein CBx is the correction dose based on blood glucose type X, BGx is the blood glucose measurement, BGTarget is a target blood glucose value of a patient, and CF is a correction factor; andwhen the determined blood glucose type is one of a pre-breakfast blood glucose measurement, a pre-lunch blood glucose measurement, or a pre-dinner blood glucose measurement: determines if a subsequent blood glucose measurement associated with a subsequent blood glucose type has been received from the glucometer:when the subsequent blood glucose measurement associated with the subsequent blood glucose type has been received, determines an adjustment factor for adjusting a next day's recommended meal bolus for the determined blood glucose type governed by the blood glucose measurement for the subsequent blood glucose type; anddetermines the next day's recommended meal bolus at the time of day associated with the determined blood glucose type by multiplying a current day's recommended meal bolus associated with the determined blood glucose type times the adjustment factor; andtransmits the correction insulin dose to an administration device in communication with the dosing controller, the administration device comprising: a doser; andan administration computing device in communication with the doser, the administration computing device configured to cause the doser to administer a number of units of insulin to the patient using the correction insulin dose.
地址 Greenville SC US